Clinical Trials Browser

Not yet recruiting × Neoplasms × tislelizumab × Clear all

NCT06456138 2024-06-13

Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC

Phase 1/2 Not yet recruiting

Neoplasms

NCT06363708 2024-04-12

Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer

Phase NA Not yet recruiting

Neoplasms, Endometrial Neoplasms